Short answer
Cardinal Health (CAH) filed an 8-K current report with the SEC on November 5, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), Item EX-99.1 (Exhibit EX-99.1). Cardinal Health announced fiscal Q1 2026 results for the quarter ended September 30, 2026.
Cardinal Health 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Cardinal Health announced fiscal Q1 2026 results for the quarter ended September 30, 2026
- Detailed financial results and management commentary are contained in Exhibit 99.1
- Results release provides the basis for assessing quarterly performance and updated investor expectations
Item 7.01 · Regulation FD Disclosure
- Webcast covers quarter ended September 30, 2026 results and fiscal 2027 outlook
- CEO and CFO presentation scheduled for November 5, 2026 at 8:30 a.m. Eastern time
- Investor slides and audio replay available at ir.cardinalhealth.com
Item EX-99.1 · Exhibit EX-99.1
- Q1 FY27 revenue $67.5B, up 5%; non-GAAP EPS $3.26, up 28%, signaling strong operating momentum
- Pharmaceutical and Specialty Solutions profit $783M, up 17%, while GMPD profit fell 28% to $33M
- FY27 non-GAAP EPS outlook raised to $12.80-$13.00 from $12.40-$12.60, with tax rate guidance lowered to 18.5%-19.5%
- $500M share repurchase completed in Q1, reducing projected diluted shares to 231-232M
- CVS distribution agreements targeted for renewal, supporting continued volume growth in the core segment
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Cardinal Health 8-K filings
Get the next CAH 8-K as it lands
Follow CAH for push alerts, or ask the research agent what this filing means.